Indegene Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for INDGN, BSE:544172 Indegene Ltd.

Search Inside the pdf :

Indegene Ltd.

10 Jul 2024

538.85

0.44%

Indegene Limited - Revolutionizing Life Sciences' Marketing Way

Buy: Indegene Ltd.

Monarch Networth Capital Limited

Number of FII/FPI investors increased from 70 to 102 in Dec 2024 qtr.

Indegene Ltd.

06 May 2024

538.85

0.44%

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. The Company has established client relationships with each of the 20 largest biopharmaceutical companies in the world.

Indegene Ltd. is trading below all available SMAs

Indegene Ltd.

03 May 2024

538.85

0.44%

IPO Note - Indegene Limited 06052024

IPO Note: Indegene Ltd.

HDFC Securities

IPO Note - Indegene Limited Indegene Limited (IL) provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products